Skip to main content
Top
Published in: AIDS and Behavior 1/2021

Open Access 01-01-2021 | Human Immunodeficiency Virus | Original Paper

Combination HIV Prevention Strategies Among Montreal Gay, Bisexual, and Other Men Who Have Sex with Men in the PrEP Era: A Latent Class Analysis

Authors: Carla M. Doyle, Mathieu Maheu-Giroux, Gilles Lambert, Sharmistha Mishra, Herak Apelian, Marc Messier-Peet, Joanne Otis, Daniel Grace, Trevor A. Hart, David M. Moore, Nathan J. Lachowsky, Joseph Cox, the Engage Study Team

Published in: AIDS and Behavior | Issue 1/2021

Login to get access

Abstract

Pre-exposure prophylaxis (PrEP) became publicly available in Quebec for gay, bisexual and other men who have sex with men (GBM) in 2013. We used baseline data from Engage, a cohort of GBM recruited by respondent-driven sampling, to examine patterns of combination HIV prevention use among Montreal GBM since PrEP became available. Latent class analysis, stratified by HIV status, was used to categorize GBM by self-reported use of biomedical and behavioural prevention strategies. Correlates of resulting classes were identified using multinomial logistic regression. Among HIV-negative/unknown GBM (n = 968), we identified four classes: low use of prevention (32%), condoms (40%), seroadaptive behaviour (21%), and biomedical (including PrEP; 7%). Those using prevention (condoms, seroadaptive behaviour, and biomedical) had a higher number of anal sex partners and were more likely to report a recent sexually transmitted infection diagnosis. GBM using biomedical prevention also had a higher level of formal education. Among GBM living with HIV (n = 200), we identified three classes: mainly antiretroviral treatment (ART) with viral suppression (53%), ART with viral suppression and condoms (19%), and ART with viral suppression and seroadaptive behaviour (18%). Again, the number of anal sex partners was higher among those using condoms and seroadaptive behaviours. Our findings show antiretroviral-based prevention, either alone or in combination with other strategies, is clearly a component of the HIV prevention landscape for GBM in Montreal. Nevertheless, PrEP uptake remains low, and there is a need to promote its availability more widely.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Institut national de santé publique du Québec. Programme de surveillance de l’infection par le virus de l’immunodéficience humaine (VIH) au Québec: Rapport Annuel 2018. Gouvernement du Québec; 2019. Institut national de santé publique du Québec. Programme de surveillance de l’infection par le virus de l’immunodéficience humaine (VIH) au Québec: Rapport Annuel 2018. Gouvernement du Québec; 2019.
5.
go back to reference Hankins CA, de Zalduondo BO. Combination prevention: a deeper understanding of effective HIV prevention. AIDS (London, England). 2010;24(Suppl 4):S70–80.CrossRef Hankins CA, de Zalduondo BO. Combination prevention: a deeper understanding of effective HIV prevention. AIDS (London, England). 2010;24(Suppl 4):S70–80.CrossRef
6.
go back to reference Joint United Nations Programme on HIV/AIDS. Combination HIV prevention: tailoring and coordinating biomedical, behavioural and structural strategies to reduce new HIV infections. 2010. Joint United Nations Programme on HIV/AIDS. Combination HIV prevention: tailoring and coordinating biomedical, behavioural and structural strategies to reduce new HIV infections. 2010.
7.
go back to reference Joint United Nations Programme on HIV/AIDS. Fast tracking combination prevention. 2015. Joint United Nations Programme on HIV/AIDS. Fast tracking combination prevention. 2015.
8.
go back to reference UNAIDS. Condom and lubricant programming in high HIV prevalence countries. 2014. UNAIDS. Condom and lubricant programming in high HIV prevalence countries. 2014.
9.
10.
go back to reference Rotheram-Borus MJ, Swendeman D, Chovnick G. The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. Annu Rev Clin Psychol. 2009;5:143–67.PubMedPubMedCentralCrossRef Rotheram-Borus MJ, Swendeman D, Chovnick G. The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. Annu Rev Clin Psychol. 2009;5:143–67.PubMedPubMedCentralCrossRef
11.
go back to reference Eaton LA, Kalichman SC, O'Connell DA, Karchner WD. A strategy for selecting sexual partners believed to pose little/no risks for HIV: serosorting and its implications for HIV transmission. AIDS Care. 2009;21(10):1279–88.PubMedPubMedCentralCrossRef Eaton LA, Kalichman SC, O'Connell DA, Karchner WD. A strategy for selecting sexual partners believed to pose little/no risks for HIV: serosorting and its implications for HIV transmission. AIDS Care. 2009;21(10):1279–88.PubMedPubMedCentralCrossRef
12.
go back to reference Philip SS, Yu X, Donnell D, Vittinghoff E, Buchbinder S. Serosorting is associated with a decreased risk of HIV seroconversion in the EXPLORE Study Cohort. PLoS ONE. 2010;5(9):e12662.PubMedPubMedCentralCrossRef Philip SS, Yu X, Donnell D, Vittinghoff E, Buchbinder S. Serosorting is associated with a decreased risk of HIV seroconversion in the EXPLORE Study Cohort. PLoS ONE. 2010;5(9):e12662.PubMedPubMedCentralCrossRef
13.
go back to reference Vallabhaneni S, Li X, Vittinghoff E, Donnell D, Pilcher CD, Buchbinder SP. Seroadaptive practices: association with HIV acquisition among HIV-negative men who have sex with men. PLoS ONE. 2012;7(10):e45718.PubMedPubMedCentralCrossRef Vallabhaneni S, Li X, Vittinghoff E, Donnell D, Pilcher CD, Buchbinder SP. Seroadaptive practices: association with HIV acquisition among HIV-negative men who have sex with men. PLoS ONE. 2012;7(10):e45718.PubMedPubMedCentralCrossRef
14.
go back to reference Grace D, Chown SA, Jollimore J, Parry R, Kwag M, Steinberg M, et al. HIV-negative gay men's accounts of using context-dependent sero-adaptive strategies. Cult Health Sex. 2014;16(3):316–30.CrossRef Grace D, Chown SA, Jollimore J, Parry R, Kwag M, Steinberg M, et al. HIV-negative gay men's accounts of using context-dependent sero-adaptive strategies. Cult Health Sex. 2014;16(3):316–30.CrossRef
15.
go back to reference Vallabhaneni S, McConnell JJ, Loeb L, Hartogensis W, Hecht FM, Grant RM, et al. Changes in seroadaptive practices from before to after diagnosis of recent HIV infection among men who have sex with men. PLoS ONE. 2013;8(2):e55397.PubMedPubMedCentralCrossRef Vallabhaneni S, McConnell JJ, Loeb L, Hartogensis W, Hecht FM, Grant RM, et al. Changes in seroadaptive practices from before to after diagnosis of recent HIV infection among men who have sex with men. PLoS ONE. 2013;8(2):e55397.PubMedPubMedCentralCrossRef
16.
go back to reference Dangerfield DT 2nd, Smith LR, Williams J, Unger J, Bluthenthal R. Sexual positioning among men who have sex with men: a narrative review. Arch Sex Behav. 2017;46(4):869–84.PubMedCrossRef Dangerfield DT 2nd, Smith LR, Williams J, Unger J, Bluthenthal R. Sexual positioning among men who have sex with men: a narrative review. Arch Sex Behav. 2017;46(4):869–84.PubMedCrossRef
17.
go back to reference Ober AJ, Dangerfield DT 2nd, Shoptaw S, Ryan G, Stucky B, Friedman SR. Using a "positive deviance" framework to discover adaptive risk reduction behaviors among high-risk HIV negative black men who have sex with men. AIDS Behav. 2018;22(5):1699–712.PubMedPubMedCentralCrossRef Ober AJ, Dangerfield DT 2nd, Shoptaw S, Ryan G, Stucky B, Friedman SR. Using a "positive deviance" framework to discover adaptive risk reduction behaviors among high-risk HIV negative black men who have sex with men. AIDS Behav. 2018;22(5):1699–712.PubMedPubMedCentralCrossRef
18.
go back to reference Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedPubMedCentralCrossRef Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedPubMedCentralCrossRef
19.
go back to reference Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316(2):171–81.PubMedCrossRef Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316(2):171–81.PubMedCrossRef
20.
go back to reference Bavinton BR, Pinto AN, Phanuphak N, Grinsztejn B, Prestage GP, Zablotska-Manos IB, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018;5(8):e438–e447447.PubMedCrossRef Bavinton BR, Pinto AN, Phanuphak N, Grinsztejn B, Prestage GP, Zablotska-Manos IB, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018;5(8):e438–e447447.PubMedCrossRef
21.
go back to reference Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;293:2428–38.CrossRef Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;293:2428–38.CrossRef
22.
go back to reference Rapid Response Service. The efficacy of post-exposure prophylaxis (PEP) for HIV. Ontario HIV Treatment Network; 2019. Rapid Response Service. The efficacy of post-exposure prophylaxis (PEP) for HIV. Ontario HIV Treatment Network; 2019.
23.
go back to reference Dominguez KL, Smith DK, Vasavi T, Crepaz N, Lang K, Heneine W, et al. Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2016. Dominguez KL, Smith DK, Vasavi T, Crepaz N, Lang K, Heneine W, et al. Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2016.
24.
go back to reference Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.PubMedCrossRef Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.PubMedCrossRef
25.
go back to reference Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV. 2017;4(9):e402–e410410.PubMedCrossRef Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV. 2017;4(9):e402–e410410.PubMedCrossRef
27.
28.
go back to reference Myers JE, Braunstein SL, Xia Q, Scanlin K, Edelstein Z, Harriman G, et al. Redefining prevention and care: a status-neutral approach to HIV. Open Forum Infect Dis. 2018;5(6):097.CrossRef Myers JE, Braunstein SL, Xia Q, Scanlin K, Edelstein Z, Harriman G, et al. Redefining prevention and care: a status-neutral approach to HIV. Open Forum Infect Dis. 2018;5(6):097.CrossRef
30.
go back to reference Office of National AIDS Policy. National HIV/AIDS strategy for the United States: updated to 2020. Washington DC: Office of National AIDS Policy; 2015. Office of National AIDS Policy. National HIV/AIDS strategy for the United States: updated to 2020. Washington DC: Office of National AIDS Policy; 2015.
31.
go back to reference National Working Group on HIV/AIDS Research. Ending the HIV epidemic in Canada in five years. Toronto: CANFAR; 2018. National Working Group on HIV/AIDS Research. Ending the HIV epidemic in Canada in five years. Toronto: CANFAR; 2018.
32.
go back to reference Otis J, McFadyen A, Haig T, Blais M, Cox J, Brenner B, et al. Beyond Condoms: Risk Reduction Strategies Among Gay, Bisexual, and Other Men Who Have Sex With Men Receiving Rapid HIV Testing in Montreal. Canada AIDS and behavior. 2016;20(12):2812–26.PubMedCrossRef Otis J, McFadyen A, Haig T, Blais M, Cox J, Brenner B, et al. Beyond Condoms: Risk Reduction Strategies Among Gay, Bisexual, and Other Men Who Have Sex With Men Receiving Rapid HIV Testing in Montreal. Canada AIDS and behavior. 2016;20(12):2812–26.PubMedCrossRef
33.
go back to reference Card KG, Lachowsky NJ, Cui Z, Carter A, Armstrong H, Shurgold S, et al. A latent class analysis of seroadaptation among gay and bisexual men. Arch Sex Behav. 2018;47(1):95–106.PubMedCrossRef Card KG, Lachowsky NJ, Cui Z, Carter A, Armstrong H, Shurgold S, et al. A latent class analysis of seroadaptation among gay and bisexual men. Arch Sex Behav. 2018;47(1):95–106.PubMedCrossRef
34.
go back to reference Ministère de la Santé et des Services sociaux. Avis intérimaire sur la prophylaxie préexposition au virus de l’immunodéficience humaine. Quebec: Gouvernment du Quebec; 2013. Ministère de la Santé et des Services sociaux. Avis intérimaire sur la prophylaxie préexposition au virus de l’immunodéficience humaine. Quebec: Gouvernment du Quebec; 2013.
35.
go back to reference Magidson J, Vermunt JK. Latent class models. The Sage handbook of quantitative methodology for the social sciences. Thousand Oaks: SAGE; 2004. p. 175–198. Magidson J, Vermunt JK. Latent class models. The Sage handbook of quantitative methodology for the social sciences. Thousand Oaks: SAGE; 2004. p. 175–198.
36.
go back to reference Collins LM, Lanza ST. Latent class and latent transition analysis : with applications in the social behavioral, and health sciences. Hoboken,: Wiley; 2010. Collins LM, Lanza ST. Latent class and latent transition analysis : with applications in the social behavioral, and health sciences. Hoboken,: Wiley; 2010.
37.
go back to reference Chan PA, Rose J, Maher J, Benben S, Pfeiffer K, Almonte A, et al. A latent class analysis of risk factors for acquiring HIV among men who have sex with men: implications for implementing pre-exposure prophylaxis programs. AIDS Patient Care STDs. 2015;29(11):597–605.PubMedPubMedCentralCrossRef Chan PA, Rose J, Maher J, Benben S, Pfeiffer K, Almonte A, et al. A latent class analysis of risk factors for acquiring HIV among men who have sex with men: implications for implementing pre-exposure prophylaxis programs. AIDS Patient Care STDs. 2015;29(11):597–605.PubMedPubMedCentralCrossRef
38.
go back to reference Tavitian-Exley I, Boily M-C, Heimer R, Uusküla A, Levina O, Maheu-Giroux M. Polydrug use and heterogeneity in HIV risk among people who inject drugs in Estonia and Russia: a latent class analysis. AIDS Behav. 2018;22(4):1329–40.PubMedCrossRef Tavitian-Exley I, Boily M-C, Heimer R, Uusküla A, Levina O, Maheu-Giroux M. Polydrug use and heterogeneity in HIV risk among people who inject drugs in Estonia and Russia: a latent class analysis. AIDS Behav. 2018;22(4):1329–40.PubMedCrossRef
39.
go back to reference Carter A, Roth EA, Ding E, Milloy MJ, Kestler M, Jabbari S, et al. Substance use, violence, and antiretroviral adherence: a latent class analysis of women living with HIV in Canada. AIDS Behav. 2018;22(3):971–85.PubMedCrossRef Carter A, Roth EA, Ding E, Milloy MJ, Kestler M, Jabbari S, et al. Substance use, violence, and antiretroviral adherence: a latent class analysis of women living with HIV in Canada. AIDS Behav. 2018;22(3):971–85.PubMedCrossRef
40.
go back to reference Card KG, Armstrong HL, Carter A, Cui Z, Wang L, Zhu J, et al. A latent class analysis of substance use and culture among gay, bisexual and other men who have sex with men. Cult Health Sex. 2018;20(12):1424–39.PubMedPubMedCentralCrossRef Card KG, Armstrong HL, Carter A, Cui Z, Wang L, Zhu J, et al. A latent class analysis of substance use and culture among gay, bisexual and other men who have sex with men. Cult Health Sex. 2018;20(12):1424–39.PubMedPubMedCentralCrossRef
41.
go back to reference Turpin RE, Slopen N, Chen S, Boekeloo B, Dallal C, Dyer T. Latent class analysis of a syndemic of risk factors on HIV testing among black men. AIDS Care. 2019;31(2):216–23.PubMedCrossRef Turpin RE, Slopen N, Chen S, Boekeloo B, Dallal C, Dyer T. Latent class analysis of a syndemic of risk factors on HIV testing among black men. AIDS Care. 2019;31(2):216–23.PubMedCrossRef
42.
go back to reference Dangerfield DT 2nd, Carmack CC, Gilreath TD, Duncan DT. Latent classes of sexual positioning practices and sexual risk among men who have sex with men in Paris,France. AIDS Behav. 2018;22(12):4001–8.PubMedCrossRef Dangerfield DT 2nd, Carmack CC, Gilreath TD, Duncan DT. Latent classes of sexual positioning practices and sexual risk among men who have sex with men in Paris,France. AIDS Behav. 2018;22(12):4001–8.PubMedCrossRef
43.
go back to reference Dangerfield DT II, Harawa NT, Smith LR, Jeffries WLT, Baezconde-Garbanati L, Bluthenthal R. Latent classes of sexual risk among black men who have sex with men and women. Arch Sex Behav. 2018;47(7):2071–80.PubMedPubMedCentralCrossRef Dangerfield DT II, Harawa NT, Smith LR, Jeffries WLT, Baezconde-Garbanati L, Bluthenthal R. Latent classes of sexual risk among black men who have sex with men and women. Arch Sex Behav. 2018;47(7):2071–80.PubMedPubMedCentralCrossRef
44.
go back to reference Wilton L, Koblin B, Nandi V, Xu G, Latkin C, Seal D, et al. Correlates of seroadaptation strategies among black men who have sex with men (MSM) in 4 US cities. AIDS Behav. 2015;19(12):2333–466.PubMedPubMedCentralCrossRef Wilton L, Koblin B, Nandi V, Xu G, Latkin C, Seal D, et al. Correlates of seroadaptation strategies among black men who have sex with men (MSM) in 4 US cities. AIDS Behav. 2015;19(12):2333–466.PubMedPubMedCentralCrossRef
45.
go back to reference Card KG, Armstrong HL, Lachowsky NJ, Cui Z, Sereda P, Carter A, et al. Belief in treatment as prevention and its relationship to HIV status and behavioral risk. J Acquir Immune Defic Syndr. 1999;77(1):8–16.CrossRef Card KG, Armstrong HL, Lachowsky NJ, Cui Z, Sereda P, Carter A, et al. Belief in treatment as prevention and its relationship to HIV status and behavioral risk. J Acquir Immune Defic Syndr. 1999;77(1):8–16.CrossRef
47.
go back to reference Card KG, Lachowsky NJ, Armstrong HL, Cui Z, Wang L, Sereda P, et al. The additive effects of depressive symptoms and polysubstance use on HIV risk among gay, bisexual, and other men who have sex with men. Addict Behav. 2018;82:158–65.PubMedPubMedCentralCrossRef Card KG, Lachowsky NJ, Armstrong HL, Cui Z, Wang L, Sereda P, et al. The additive effects of depressive symptoms and polysubstance use on HIV risk among gay, bisexual, and other men who have sex with men. Addict Behav. 2018;82:158–65.PubMedPubMedCentralCrossRef
48.
go back to reference Rooks-Peck CR, Adegbite AH, Wichser ME, Ramshaw R, Mullins MM, Higa D, et al. Mental health and retention in HIV care: a systematic review and meta-analysis. Health Psychol. 2018;37(6):574–85.PubMedPubMedCentralCrossRef Rooks-Peck CR, Adegbite AH, Wichser ME, Ramshaw R, Mullins MM, Higa D, et al. Mental health and retention in HIV care: a systematic review and meta-analysis. Health Psychol. 2018;37(6):574–85.PubMedPubMedCentralCrossRef
49.
go back to reference Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS (London, England). 2005;19(Suppl 2):S67–72.CrossRef Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS (London, England). 2005;19(Suppl 2):S67–72.CrossRef
50.
go back to reference White RG, Hakim AJ, Salganik MJ, Spiller MW, Johnston LG, Kerr L, et al. Strengthening the reporting of observational studies in epidemiology for respondent-driven sampling studies: "STROBE-RDS" statement. J Clin Epidemiol. 2015;68(12):1463–71.PubMedPubMedCentralCrossRef White RG, Hakim AJ, Salganik MJ, Spiller MW, Johnston LG, Kerr L, et al. Strengthening the reporting of observational studies in epidemiology for respondent-driven sampling studies: "STROBE-RDS" statement. J Clin Epidemiol. 2015;68(12):1463–71.PubMedPubMedCentralCrossRef
51.
go back to reference Reilly KH, Neaigus A, Jenness SM, Wendel T, Hagan H, Marshall DMT, et al. Trends in HIV prevalence and risk behavior among men who have sex with men in New York City, 2004–2011. AIDS Educ Prev. 2014;26(2):134–43.PubMedCrossRefPubMedCentral Reilly KH, Neaigus A, Jenness SM, Wendel T, Hagan H, Marshall DMT, et al. Trends in HIV prevalence and risk behavior among men who have sex with men in New York City, 2004–2011. AIDS Educ Prev. 2014;26(2):134–43.PubMedCrossRefPubMedCentral
52.
go back to reference Sanchez TH, Zlotorzynska M, Sineath RC, Kahle E, Tregear S, Sullivan PS. National trends in sexual behavior, substance use and HIV testing among united states men who have sex with men recruited online, 2013 through 2017. AIDS Behav. 2018;22(8):2413–25.PubMedCrossRef Sanchez TH, Zlotorzynska M, Sineath RC, Kahle E, Tregear S, Sullivan PS. National trends in sexual behavior, substance use and HIV testing among united states men who have sex with men recruited online, 2013 through 2017. AIDS Behav. 2018;22(8):2413–25.PubMedCrossRef
53.
go back to reference Hayes R, Kapiga S, Padian N, McCormack S, Wasserheit J. HIV prevention research: taking stock and the way forward. AIDS (London, England). 2010;24(Suppl 4):S81–S92.PubMedCentralCrossRef Hayes R, Kapiga S, Padian N, McCormack S, Wasserheit J. HIV prevention research: taking stock and the way forward. AIDS (London, England). 2010;24(Suppl 4):S81–S92.PubMedCentralCrossRef
54.
go back to reference Oberski DL. Beyond the number of classes: separating substantive from non-substantive dependence in latent class analysis. Adv Data Anal Classif. 2016;10(2):171–82.CrossRef Oberski DL. Beyond the number of classes: separating substantive from non-substantive dependence in latent class analysis. Adv Data Anal Classif. 2016;10(2):171–82.CrossRef
55.
go back to reference Hagenaars JA. Latent structure models with direct effects between indicators: local dependence models. Sociol Methods Res. 1988;16(3):379–405.CrossRef Hagenaars JA. Latent structure models with direct effects between indicators: local dependence models. Sociol Methods Res. 1988;16(3):379–405.CrossRef
56.
go back to reference Asparouhov T, Muthén B. Residual associations in latent class and latent transition analysis. Struct Equ Model A. 2015;22(2):169–77.CrossRef Asparouhov T, Muthén B. Residual associations in latent class and latent transition analysis. Struct Equ Model A. 2015;22(2):169–77.CrossRef
57.
go back to reference Cover TM, Thomas JA. Elements of information theory. 2nd ed. Hoboken: Wiley-Interscience; 2006. Cover TM, Thomas JA. Elements of information theory. 2nd ed. Hoboken: Wiley-Interscience; 2006.
58.
go back to reference Volz E, Heckathorn DD. Probability based estimation theory for respondent driven sampling. J Off Stat. 2008;24(1):79. Volz E, Heckathorn DD. Probability based estimation theory for respondent driven sampling. J Off Stat. 2008;24(1):79.
59.
go back to reference Ronn M, White PJ, Hughes G, Ward H. Developing a conceptual framework of seroadaptive behaviors in HIV-diagnosed men who have sex with men. J Infect Dis. 2014;210(Suppl 2):S586–S593593.PubMedPubMedCentralCrossRef Ronn M, White PJ, Hughes G, Ward H. Developing a conceptual framework of seroadaptive behaviors in HIV-diagnosed men who have sex with men. J Infect Dis. 2014;210(Suppl 2):S586–S593593.PubMedPubMedCentralCrossRef
60.
go back to reference Pines HA, Gorbach PM, Weiss RE, Reback CJ, Landovitz RJ, Mutchler MG, et al. Individual-level, partnership-level, and sexual event-level predictors of condom use during receptive anal intercourse among HIV-negative men who have sex with men in Los Angeles. AIDS Behav. 2016;20(6):1315–26.PubMedPubMedCentralCrossRef Pines HA, Gorbach PM, Weiss RE, Reback CJ, Landovitz RJ, Mutchler MG, et al. Individual-level, partnership-level, and sexual event-level predictors of condom use during receptive anal intercourse among HIV-negative men who have sex with men in Los Angeles. AIDS Behav. 2016;20(6):1315–26.PubMedPubMedCentralCrossRef
61.
go back to reference Lambert G, Cox J, Hottes TS, Tremblay C, Frigault LR, Alary M, et al. Correlates of unprotected anal sex at last sexual episode: analysis from a surveillance study of men who have sex with men in Montreal. AIDS Behav. 2011;15(3):584–95.PubMedCrossRef Lambert G, Cox J, Hottes TS, Tremblay C, Frigault LR, Alary M, et al. Correlates of unprotected anal sex at last sexual episode: analysis from a surveillance study of men who have sex with men in Montreal. AIDS Behav. 2011;15(3):584–95.PubMedCrossRef
62.
go back to reference Van de Ven P, Crawford J, Kippax S, Knox S, Prestage G. A scale of optimism-scepticism in the context of HIV treatments. AIDS Care. 2000;12(2):171–6.PubMedCrossRef Van de Ven P, Crawford J, Kippax S, Knox S, Prestage G. A scale of optimism-scepticism in the context of HIV treatments. AIDS Care. 2000;12(2):171–6.PubMedCrossRef
63.
go back to reference Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158(16):1789–95.PubMedCrossRef Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158(16):1789–95.PubMedCrossRef
64.
go back to reference Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31(7):1208–17.PubMedCrossRef Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31(7):1208–17.PubMedCrossRef
65.
go back to reference Solon G, Haider SJ, Wooldridge JM. What are we weighting for? J Hum Resour. 2015;50(2):301–16.CrossRef Solon G, Haider SJ, Wooldridge JM. What are we weighting for? J Hum Resour. 2015;50(2):301–16.CrossRef
67.
go back to reference Linzer DA, Lewis JB. poLCA: an R package for polytomous variable latent class analysis. J Stat Softw. 2011;42(10):1–29.CrossRef Linzer DA, Lewis JB. poLCA: an R package for polytomous variable latent class analysis. J Stat Softw. 2011;42(10):1–29.CrossRef
68.
go back to reference Zeileis A, Lumley T, Berger S, Graham N. Package ‘sandwich’. R package version 2.5–1. 2019. Zeileis A, Lumley T, Berger S, Graham N. Package ‘sandwich’. R package version 2.5–1. 2019.
69.
go back to reference Braine N, van Sluytman L, Acker C, Friedman S, Des Jarlais DC. Sexual contexts and the process of risk reduction. Cult Health Sex. 2011;13(7):797–814.PubMedCrossRef Braine N, van Sluytman L, Acker C, Friedman S, Des Jarlais DC. Sexual contexts and the process of risk reduction. Cult Health Sex. 2011;13(7):797–814.PubMedCrossRef
70.
go back to reference Jenness SM, Goodreau SM, Rosenberg E, Beylerian EN, Hoover KW, Smith DK, et al. Impact of the centers for disease control's HIV preexposure prophylaxis guidelines for men who have sex with men in the United States. J Infect Dis. 2016;214(12):1800–7.PubMedPubMedCentralCrossRef Jenness SM, Goodreau SM, Rosenberg E, Beylerian EN, Hoover KW, Smith DK, et al. Impact of the centers for disease control's HIV preexposure prophylaxis guidelines for men who have sex with men in the United States. J Infect Dis. 2016;214(12):1800–7.PubMedPubMedCentralCrossRef
71.
go back to reference Kasaie P, Pennington J, Shah MS, Berry SA, German D, Flynn CP, et al. The impact of preexposure prophylaxis among men who have sex with men: an individual-based model. J Acquir Immune Defic Syndr. 1999;75(2):175–83.CrossRef Kasaie P, Pennington J, Shah MS, Berry SA, German D, Flynn CP, et al. The impact of preexposure prophylaxis among men who have sex with men: an individual-based model. J Acquir Immune Defic Syndr. 1999;75(2):175–83.CrossRef
72.
go back to reference Scott N, Stoove M, Kelly SL, Wilson DP, Hellard ME. Achieving 90–90-90 human immunodeficiency virus (HIV) targets will not be enough to achieve the HIV incidence reduction target in Australia. Clin Infect Dis. 2018;66(7):1019–23.PubMedCrossRef Scott N, Stoove M, Kelly SL, Wilson DP, Hellard ME. Achieving 90–90-90 human immunodeficiency virus (HIV) targets will not be enough to achieve the HIV incidence reduction target in Australia. Clin Infect Dis. 2018;66(7):1019–23.PubMedCrossRef
73.
go back to reference Ministère de la Santé et des Services sociaux. La prophylaxie préexposition au virus de l’immunodéficience humaine: guide pour les professionnels de la santé du Québec. Québec: Gouvernement du Québec; 2017. Ministère de la Santé et des Services sociaux. La prophylaxie préexposition au virus de l’immunodéficience humaine: guide pour les professionnels de la santé du Québec. Québec: Gouvernement du Québec; 2017.
74.
go back to reference Greenwald ZR, Maheu-Giroux M, Szabo J, Robin JAB, Boissonnault M, Nguyen VK, et al. Cohort profile: l'Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study in Montreal, Canada. BMJ Open. 2019;9(6):e028768.PubMedPubMedCentralCrossRef Greenwald ZR, Maheu-Giroux M, Szabo J, Robin JAB, Boissonnault M, Nguyen VK, et al. Cohort profile: l'Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study in Montreal, Canada. BMJ Open. 2019;9(6):e028768.PubMedPubMedCentralCrossRef
75.
go back to reference Martinez JE, Jonas KJ. Pre-exposure prophylaxis sorting among men who have sex with men. AIDS Care. 2019;31(3):388–96.PubMedCrossRef Martinez JE, Jonas KJ. Pre-exposure prophylaxis sorting among men who have sex with men. AIDS Care. 2019;31(3):388–96.PubMedCrossRef
76.
go back to reference Rojas Castro D, Delabre RM, Molina JM. Give PrEP a chance: moving on from the "risk compensation" concept. J Int AIDS Soc. 2019;22(Suppl 6):e25351.PubMedPubMedCentral Rojas Castro D, Delabre RM, Molina JM. Give PrEP a chance: moving on from the "risk compensation" concept. J Int AIDS Soc. 2019;22(Suppl 6):e25351.PubMedPubMedCentral
77.
go back to reference Holt M, Murphy DA. Individual versus community-level risk compensation following preexposure prophylaxis of HIV. Am J Public Health. 2017;107(10):1568–71.PubMedPubMedCentralCrossRef Holt M, Murphy DA. Individual versus community-level risk compensation following preexposure prophylaxis of HIV. Am J Public Health. 2017;107(10):1568–71.PubMedPubMedCentralCrossRef
78.
go back to reference Duchesne L, Lydié N, Velter A. Increase in the overall level of protected anal sex in men who have sex with men in France: results from the repeated cross-sectional survey Rapport au Sexe, France, 2017–2019. AIDS Care. 2020;32(sup2):162–9.PubMedCrossRef Duchesne L, Lydié N, Velter A. Increase in the overall level of protected anal sex in men who have sex with men in France: results from the repeated cross-sectional survey Rapport au Sexe, France, 2017–2019. AIDS Care. 2020;32(sup2):162–9.PubMedCrossRef
79.
go back to reference Chen YH, Snowden JM, McFarland W, Raymond HF. Pre-exposure prophylaxis (PrEP) use, seroadaptation, and sexual behavior among men who have sex with men, San Francisco, 2004–2014. AIDS Behav. 2016;20(12):2791–7.PubMedCrossRef Chen YH, Snowden JM, McFarland W, Raymond HF. Pre-exposure prophylaxis (PrEP) use, seroadaptation, and sexual behavior among men who have sex with men, San Francisco, 2004–2014. AIDS Behav. 2016;20(12):2791–7.PubMedCrossRef
80.
go back to reference Grov C, Jonathan Rendina H, Patel VV, Kelvin E, Anastos K, Parsons JT. Prevalence of and factors associated with the use of HIV serosorting and other biomedical prevention strategies among men who have sex with men in a US Nationwide Survey. AIDS Behav. 2018;22(8):2743–55.PubMedPubMedCentralCrossRef Grov C, Jonathan Rendina H, Patel VV, Kelvin E, Anastos K, Parsons JT. Prevalence of and factors associated with the use of HIV serosorting and other biomedical prevention strategies among men who have sex with men in a US Nationwide Survey. AIDS Behav. 2018;22(8):2743–55.PubMedPubMedCentralCrossRef
81.
83.
go back to reference Santelli JS, Smith Rogers A, Rosenfeld WD, DuRant RH, Dubler N, Morreale M, et al. Guidelines for adolescent health research. A position paper of the society for adolescent medicine. J Adolesc Health. 2003;33(5):396–409.PubMed Santelli JS, Smith Rogers A, Rosenfeld WD, DuRant RH, Dubler N, Morreale M, et al. Guidelines for adolescent health research. A position paper of the society for adolescent medicine. J Adolesc Health. 2003;33(5):396–409.PubMed
Metadata
Title
Combination HIV Prevention Strategies Among Montreal Gay, Bisexual, and Other Men Who Have Sex with Men in the PrEP Era: A Latent Class Analysis
Authors
Carla M. Doyle
Mathieu Maheu-Giroux
Gilles Lambert
Sharmistha Mishra
Herak Apelian
Marc Messier-Peet
Joanne Otis
Daniel Grace
Trevor A. Hart
David M. Moore
Nathan J. Lachowsky
Joseph Cox
the Engage Study Team
Publication date
01-01-2021
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2021
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-020-02965-4

Other articles of this Issue 1/2021

AIDS and Behavior 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine